Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
ADVM holding history
Adverum Biotechnologies, Inc. in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADVM overviewAll 13F holders of ADVMFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −7,923−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q4 2023 | 79,234 | $59.6K | <0.1% | +20,000+33.8% | Added | Holders |
| Q3 2023 | 59,234 | $88.9K | <0.1% | −175,766−74.8% | Reduced | Holders |
| Q2 2023 | 235,000 | $373.6K | 0.2% | −424,575−64.4% | Reduced | Holders |
| Q1 2023 | 659,575 | $473.2K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2022 | 659,575 | $382.2K | 0.1% | +434,575+193.1% | Added | Holders |
| Q3 2022 | 225,000 | $214.0K | 0.1% | −222,004−49.7% | Reduced | Holders |
| Q2 2022 | 447,004 | $536.0K | 0.2% | +447,004 | New | Holders |